Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.03.2024 | Case report

Axicabtagene-ciloleucel

Cytokine release syndrome, Immune effector cell-associated neurotoxicity syndrome and right ventricular conduction delay

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Easwar N, et al. Axicabtagene Ciloleucel in Patients Aged 75 and Older: A Retrospective Cohort Study. Blood 142 (Suppl. 1): 6318, Nov 2023. Available from: URL: https://dx.doi.org/10.1182/blood-2023-178187 [abstract] Easwar N, et al. Axicabtagene Ciloleucel in Patients Aged 75 and Older: A Retrospective Cohort Study. Blood 142 (Suppl. 1): 6318, Nov 2023. Available from: URL: https://dx.doi.org/10.1182/blood-2023-178187 [abstract]
Metadaten
Titel
Axicabtagene-ciloleucel
Cytokine release syndrome, Immune effector cell-associated neurotoxicity syndrome and right ventricular conduction delay
Publikationsdatum
01.03.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-54374-1

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Multiple drugs

Case report

Tacrolimus